The role of Rel/NF-κB proteins in viral oncogenesis and the regulation of viral transcription

Seminars in Cancer Biology

Volumn 8, Issue 2, 1997, Pages 121-129

  Mosialos, George ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Epstein Barr virus; Malignant transformation; NF B; Signal transduction; Tax protein

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR; UBIQUITIN;

APOPTOSIS; CARCINOGENESIS; CELL GROWTH; CELL NUCLEUS; CELL SURVIVAL; CYTOPLASM; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMAN; IMMUNOMODULATION; MALIGNANT TRANSFORMATION; NONHUMAN; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; REVIEW; SIGNAL TRANSDUCTION; VIRUS CELL TRANSFORMATION; VIRUS GENE; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

EID: 0031126817     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1006/scbi.1997.0063     Document Type: Article

References (70)

1. 1. Yoshida M (1995) HTLV-1 oncoprotein Tax deregulates transcription of cellular genes through multiple mechanisms. J Cancer Res Clin Oncol 121:521-528
2. 2. Grassman R, Dengler C, Muller-Fleckenstein I, Fleckenstein B, McGuire K, Dokhelar M, Sodroski J, Haseltine W (1989) Transformation to continuous growth of primary human T lymphocytes by human T cell leukemia virus type I X-region genes transduced by a Herpes virus saimiri vector. Proc Natl Acad Sci USA 86:3351-3355
3. 3. Tanaka A, Takahashi C, Yamaoka S, Nosaka T, Maki M, Hatanaka M (1990) Oncogenic transformation by the tax gene of human T-cell leukemia virus type I in vitro. Proc Natl Acad Sci USA 87:1071-1075
4. 4. Smith MR, Greene WC (1991) Type I human T cell leukemia virus tax protein transforms rat fibroblasts through the cyclic adenosine monophosphate response element binding protein/activating transcription factor pathway. J Clin Invest 88:1038-1042
5. 5. Fujii M, Tsuchiya H, Seiki M (1991) HTLV-1 Tax has distinct but overlapping domains for transcriptional activation and for enhancer specificity. Oncogene 6:2349-2352
6. 6. Fujisawa J, Toita M, Yoshimura T, Yoshida M (1991) The indirect association of human T-cell leukemia virus tax protein with DNA results in transcriptional activation. J Virol 65:4525-4528
7. 7. Kanno T, Brown K, Franzoso G, Siebenlist U (1994) Kinetic analysis of human T-cell leukemia virus type I Tax-mediated activation of NF-κB. Mol Cell Biol 14:6443-6451
8. 8. Sun SC, Elwood J, Beraud C, Greene WC (1994) Human T-cell leukemia virus type I Tax activation of NF-κB/ Rel involves phosphorylation and degradation of IκBα and RelA (p65)-mediated induction of the c-rel gene. Mol Cell Biol 14:7377-7384
9. 9. Miyamoto S, Chiao PL, Verma IM (1994) Enhanced IκBα degradation is responsible for constitutive NF-κB activity in mature murine B-cell lines. Mol Cell Biol 14:3276-3282
10. 10. Suzuki T, Hirai H, Murakami T, Yoshida M (1995) Tax protein of HTLV-1 destabilizes the complexes of NF-κB and IκB-α and induces nuclear translocation of NF-κB for transcriptional activation. Oncogene 10:1199-1207
11. 11. Lindholm PF, Tamami M, Makowski J, Brady JN (1996) Human T-cell lymphotropic virus type 1 Tax 1 activation of NF-κB: involvement of the protein kinase C pathway. J Virol 70:2525-2532
12. 12. Lee FS, Hagler J, Chen ZJ, Maniatis T (1997) Activation of the IκBα kinase complex by MEKK1, a kinase of the JNK path way. Cell 88:213-222
13. 13. Good L, Sun SC (1996) Persistent activation of NF-κB/ Rel by human T-cell leukemia virus type 1 Tax involves degradation of IκBβ. J Virol 70:2730-2735
14. 14. McKinsey TA, Brockman JA, Sherer DC, Al-Murrani SW, Green PL, Ballard DW (1996) Inactivation of IκBβ by the Tax protein of human T cell leukemia virus type I: a potential mechanism for constitutive induction of NF-κB. Mol Cell Biol 16:2083-2090
15. 15. Hirai H, Fujisawa J, Suzuki T, Ueda K, Muramatsu M, Tsuboi A, Arai N, Yoshida M (1992) Transcriptional activator Tax of HTLV-1 binds to the NF-κB precursor p105. Oncogene 7:1737-1742
16. 16. Béraud C, Sun SC, Ganchi P, Ballard DW, Greene WC (1994) Human T-cell leukemia virus type I Tax associates with and is negatively regulated by the NF-κB2 p100 gene product: implications for viral latency. Mol Cell Biol 14:1374-1382
17. 17. Kanno T, Franzoso G, Siebenlist U (1994) Human T-cell leukemia virus type I Tax-protein-mediated activation of NF-κB from p100 (NF-κB2)-inhibited cytoplasmic reservoirs. Proc Natl Acad Sci USA 91:12634-12638
18. 18. Munoz E, Courtois G, Veschambre P, Jalinot P, Israël A (1994) Tax induces nuclear translocation of NF-κB through dissociation of cytoplasmic complexes containing p105 or p100 but does not induce degradation of IκBα/MAD3. J Virol 68:8035-8044
19. 19. Murakami T, Hirai H, Suzuki T, Fujisawa J, Yoshida M (1995) HTLV-1 Tax enhances NF-κB2 expression and binds to the products p52 and p100, but does not suppress the inhibitory function of p100. Virology 206:1066-1074
20. 20. Rousset R, Desbois C, Bantignies F, Jalinot P (1996) Effects on NF-κB1/ p105 processing of the interaction between the HTLV-1 transactivator Tax and the proteasome. Nature 381:328-331
21. 21. Watanabe M, Muramatsu M, Tsuboi A, Arai K (1994) Differential response of NF-κB1 p105 and NF-κB2 p100 to HTLV-I encoded Tax. FEBS Lett 342:115-118
22. 22. Hirai H, Suzuki T, Fujisawa J, Inoue J, Yoshida M (1994) Tax protein of human T-cell leukemia virus type I binds to the ankyrin motifs of inhibitory factor κB and induces nuclear translocation of transcription factor NF-κB proteins for transcriptional activation. Proc Natl Acad Sci USA 91:3584-3588
23. 23. Smith MR, Greene WC (1990) Identification of HTLV-I Tax trans-activator mutants exhibiting novel transcriptional phenotypes. Genes Dev 4:1875-1885
24. 24. Suzuki T, Hirai H, Yoshida M (1994) Tax protein of HTLV-1 interacts with the Rel homology domain of NF-κB p65 and c-Rel proteins bound to the NF-κB binding site and activates transcription. Oncogene 9:3099-3105
25. 25. Ross TM, Pettiford SM, Green PL (1996) The tax gene of human T-cell leukemia virus type 2 is essential for transformation of human T lymphocytes. J Virol 70:5194-5202
26. 26. Kitajima I, Shinohara T, Bilakovics J, Brown DA, Xu X, Nerenberg M (1992) Ablation of transplanted HTLV-I Tax-transformed tumors in mice by antisense inhibition of NF-κB. Science 258:1792-1795
27. 27. Yamaoka S, Inoue H, Sakurai M, Sugiyama T, Hazama M, Yamada T, Hatanaka M (1996) Constitutive activation of NF-κB is essential for transformation of rat fibroblasts by the human T-cell leukemia virus type I Tax protein. EMBO J 15:873-887
28. INK4α. J Virol 71:1956-1962
29. 29. Rickinson AB, Kieff E (1996) Epstein-Barr virus, in Virology (Fields BN, Knipe DM, Howley PM, eds) pp 2397-2446. Raven Press, New York
30. 30. Kieff E (1996) Epstein-Barr virus and its replication, in Virology (Fields BN, Knipe DM, Howley PM, eds) pp 2343-2496. Raven Press, New York
31. 31. Kaye KM, Izumi KM, Kieff E (1993) Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc Natl Acad Sci USA 90:9150-9154
32. 32. Wang D, Liebowitz D, Kieff E (1985) An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43:831-840
33. 33. Baichwal VR, Sugden B (1988) Transformation of Balb/ 3T3 cells by the BNLF-1 gene of Epstein-Barr virus. Oncogene 4:67-74
34. 34. Dawson CW, Rickinson AB, Young LS (1990) Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation. Nature 344:777-780
35. 35. Fahraeus R, Rymo L, Rhim JS, Klein G (1990) Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus. Nature 345:447-449
36. 36. Wilson JB, Weinberg W, Johnson R, Yuspa S, Levine AJ (1990) Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6. Cell 61:1315-1327
37. 37. Wang F, Gregory C, Sample C, Rowe M, Liebowitz D, Murray R, Rickinson A, Kieff E (1990) Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. J. Virol 64:2309-2318
38. 38. Henderson S, Rowe M, Gregory C, Croom-Carter D, Wang F, Longnecker R, Kieff E, Rickinson A (1991) Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65:1107-1115
39. 39. Laherty CD, Hu HM, Opipari AW, Wang F, Dixit VM (1992) The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor κB. J Biol Chem 267:24157-24160
40. 40. Huen DS, Henderson SA, Croom-Carter D, Rowe M (1995) The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-κB and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene 10:549-560
41. 41. Mitchell T, Sugden B (1995) Stimulation of NF-κB-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus. J Virol 69:2968-2976
42. 42. Izumi KM, Kaye KM, Kieff ED (1997) The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation. Proc Natl Acad Sci USA 94:1447-1452
43. 43. Kaye KM, Izumi KM, Mosialos G, Kieff E (1995) The Epstein-Barr virus LMP1 cytoplasmic carboxy terminus is essential for B-lymphocyte transformation; fibroblast cocultivation complements a critical function within the terminal 155 residues. J Virol 69:675-683
44. 44. Mosialos G, Birkenbach M, Yalamanchili R, Van Arsdale T, Ware C, Kieff E (1995) The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80:389-399
45. 45. Devergne O, Hatzivassiliou E, Izumi KM, Kaye KM, Kleijnen MF, Kieff E, Mosialos G (1996) Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-κB activation. Mol Cell Biol 16:7098-7108
46. 46. Kaye KM, Devergne O, Harada JN, Izumi KM, Yalamanchili R, Kieff E, Mosialos G (1996) Tumor necrosis factor receptor associated factor 2 is a mediator of NF-κB activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein. Proc Natl Acad Sci USA 93:11085-11090
47. 47. Shu HB, Takeuchi M, Goeddel DV (1996) The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex. Proc Natl Acad Sci USA 93:13973-13978
48. 48. Van Arsdale TL, Van Arsdale SL, Force WR, Walter BN, Mosialos G, Kieff E, Reed JC, Ware CF (1997) Lymphotoxin-β receptor signaling complex: the role of TRAF3 recruitment in cell death and activation of nuclear factor κB. Proc Natl Acad Sci USA 94:2460-2465
49. 49. Malinin NL, Boldin MP, Kovalenko AV, Wallach D (1997) MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1. Nature 385:540-544
50. 50. Herrero JA, Mathew P, Paya CV (1995) LMP-1 activates NF-κB by targeting the inhibitory molecule IκBα. J Virol 69:2168-2174
51. 51. Paine E, Scheinman RI, Baldwin AS Jr, Raab-Traub N (1995) Expression of LMP1 in epithelial cells leads to the activation of a select subset of NF-κB/ Rel family proteins. J Virol 69:4572-4576
52. 52. Pathmanathan R, Prasad U, Sadler R, Flynn K, Raab-Traub N (1995) Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl JMed 333:693-698
53. 53. Scala G, Quinto I, Ruocco MR, Mallardo M, Ambrosino C, Squitieri B, Tassone P, Venuta S (1993) Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1. J Virol 67:2853-2861
54. 54. Shirakata Y, Kawada M, Fujiki Y, Sano H, Oda M, Yaginuma K, Kobayashi M, Koike K (1989) The X gene of hepatitis B virus induced growth stimulation and tumorigenic transformation of mouse NIH3T3 cells. Jpn J Cancer Res 80:617-621
55. 55. Koike K, Moriya K, Iino S, Yotsuyanagi H, Endo Y, Miyamura T, Kurokawa K (1994) High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice. Hepatology 19:810-819
56. 56. Doria M, Klein N, Lucito R, Schneider RJ (1995) The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors. EMBO J 14:4747-4757
57. 57. Benn J, Schneider RJ (1994) Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. Proc Natl Acad Sci USA 91:10350-10354
58. 58. Su F, Schneider RJ (1996) Hepatitis B virus HBx protein activates transcription factor NF-κB by acting on multiple cytoplasmic inhibitors of rel-related proteins. J Virol 70:4558-4566
59. 59. Kekule AS, Lauer U, Weiss L, Luber B, Hofschneider PH (1993) Hepatitis B virus transactivator HBx uses a tumor promoter signalling pathway. Nature 361:742-745
60. 60. Chirillo P, Falco M, Puri PL, Artini M, Balsano C, Levrero M, Natoli G (1996) Hepatitis B virus pX activates NF-κB-dependent transcription through a Raf-independent pathway. J Virol 70:641-646
61. 61. Nabel D, Baltimore D (1987) An inducible transcription factor activates expression of a human immunodeficiency virus. Nature 326:711-713
62. 62. Williams JL, Garcia J, Harrich D, Pearson L, Wu F, Gaynor R (1990) Lymphoid specific gene expression of the adenovirus early region 3 promoter is mediated by NF-κB binding motifs. EMBO J 9:4435-4442
63. 63. Mayreddy RP, Safak M, Razmara M, Zoltick P, Khalili K (1996) Transcription of the JC virus archetype late genome: importance of the κB and the 23-base-pair motifs in late promoter activity in glial cells. J Virol 70:2387-2393
64. 64. Sambucetti LC, Cherrington JM, Wilkinson GW, Mocarski ES (1989) NF-κB activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation. EMBO J 8:4251-4258
65. 65. Rong BL, Libermann TA, Kogawa K, Ghosh S, Cao LX, Pavan-Langston D, Dunkel EC (1992) HSV-1-inducible proteins bind to NF-κB-like sites in the HSV-1 genome. Virology 189:750-756
66. 66. Graves BJ, Rabson AB (1997) Retrovirus Gene Expression: Transcription and RNA Processing, in Retroviruses (Coffin JM, Hughes SH, Varmus HE, eds). Cold Spring Harbor Laboratory Press, in press
67. 67. Perkins ND, Edwards NL, Duckett CS, Agranoff AB, Schmid RM, Nabel GJ (1993) A cooperative interaction between NF-κB and Sp1 is required for HIV-1 enhancer activation. EMBO J 12:3551-3558
68. 68. Leonard J, Parrott C, Buckler-White AJ, Turner W, Ross EK, Martin MA, Rabson AB (1989) The NF-κB binding sites in the human immunodeficiency virus type 1 long terminal repeat are not required for virus infectivity. J Virol 63:4919-4924
69. 69. Ross EK, Buckler-White WJ, Rabson AB, Englund G, Martin MA (1991) Contribution of NF-κB and Sp1 binding motifs to the replicative capacity of human immunodeficiency virus type 1: distinct patterns of viral growth are determined by T-cell types. J Virol 65:4350-4358
70. 70. Yurochko AD, Kowalik TF, Huong SM, Huang ES (1995) Human cytomegalovirus upregulates NF-κB activity by transactivating the NF-κB p105/ p50 and p65 promoters. J Virol 69:5391-5400